Center Laboratories, Inc.(TW:4123)
NT$28.40+0.15 (+0.53%)
TW:4123
Center Laboratories, Inc. financials statements
NT$28.40
At close:+0.15 (+0.53%)
Center Laboratories, Inc. (4123) Ratios
Center Laboratories, Inc. Ratios
TW:4123's free cash flow for Q2 2026 was NT$94.48M. For the 2026 fiscal year, TW:4123's free cash flow was decreased by NT$-31.64M and operating cash flow was NT$126.12M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Mar 23 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.45 | 0.82 | 2.78 | 0.73 | 4.06 |
| Quick Ratio | 0.35 | 0.75 | 2.63 | 0.70 | 4.03 |
| Cash Ratio | 0.07 | 0.31 | 0.92 | 0.20 | 0.10 |
| Solvency Ratio | 1.17 | -0.13 | -0.12 | -0.09 | 0.20 |
| Operating Cash Flow Ratio | 0.01 | 0.09 | -0.52 | -0.05 | -0.13 |
| Short-Term Operating Cash Flow Coverage | 0.01 | 0.11 | -0.81 | -0.09 | -0.21 |
| Net Current Asset Value | NT$ -6.55B | NT$ -3.70B | NT$ -1.66B | NT$ -3.08B | NT$ 1.54B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.14 | 0.26 | 0.21 | 0.14 | 0.17 |
| Debt-to-Equity Ratio | 0.18 | 0.36 | 0.28 | 0.18 | 0.28 |
| Debt-to-Capital Ratio | 0.15 | 0.27 | 0.22 | 0.15 | 0.22 |
| Long-Term Debt-to-Capital Ratio | 0.06 | 0.13 | 0.18 | 0.06 | 0.16 |
| Financial Leverage Ratio | 1.31 | 1.41 | 1.37 | 1.31 | 1.61 |
| Debt Service Coverage Ratio | 3.10 | -0.04 | -0.50 | 0.11 | 1.28 |
| Interest Coverage Ratio | -1.77 | 1.03 | 0.39 | 1.60 | 10.17 |
| Debt to Market Cap | 0.16 | 0.23 | 0.21 | 0.14 | 0.19 |
| Interest Debt Per Share | 6.49 | 9.52 | 8.78 | 5.52 | 8.46 |
| Net Debt to EBITDA | 0.37 | -21.90 | -5.12 | 11.51 | 1.83 |
| Profitability Margins | |||||
| Gross Profit Margin | 40.97% | 46.29% | 44.34% | 52.92% | 51.92% |
| EBIT Margin | 776.49% | -24.32% | -65.55% | 25.98% | 539.56% |
| EBITDA Margin | 787.92% | -14.37% | -54.93% | 30.28% | 546.48% |
| Operating Profit Margin | -23.85% | 14.48% | 5.63% | 17.19% | 208.89% |
| Pretax Profit Margin | 763.01% | -72.32% | -79.91% | -76.71% | 519.02% |
| Net Profit Margin | 614.89% | -68.22% | -71.41% | -74.98% | 363.16% |
| Continuous Operations Profit Margin | 614.89% | -68.20% | -75.15% | -74.98% | 234.69% |
| Net Income Per EBT | 80.59% | 94.33% | 89.36% | 97.74% | 69.97% |
| EBT Per EBIT | -3199.11% | -499.33% | -1418.33% | -446.36% | 248.47% |
| Return on Assets (ROA) | 26.92% | -4.32% | -3.69% | -2.29% | 5.97% |
| Return on Equity (ROE) | 35.20% | -6.11% | -5.04% | -2.99% | 9.59% |
| Return on Capital Employed (ROCE) | -1.16% | 1.12% | 0.31% | 0.62% | 3.76% |
| Return on Invested Capital (ROIC) | -0.86% | 0.89% | 0.28% | 0.55% | 2.95% |
| Return on Tangible Assets | 27.50% | -4.46% | -3.80% | -2.29% | 5.97% |
| Earnings Yield | 31.12% | -3.91% | -3.73% | -2.29% | 6.58% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.47 | 7.98 | 5.18 | 4.06 | 0.87 |
| Payables Turnover | 7.50 | 6.50 | 5.45 | 3.81 | 8.29 |
| Inventory Turnover | 2.53 | 2.81 | 2.88 | 4.05 | 2.39 |
| Fixed Asset Turnover | 0.82 | 1.13 | 1.02 | 1.44 | 0.67 |
| Asset Turnover | 0.04 | 0.06 | 0.05 | 0.03 | 0.02 |
| Working Capital Turnover Ratio | -1.10 | 1.33 | 1.26 | 0.22 | 0.15 |
| Cash Conversion Cycle | 151.90 | 119.69 | 130.15 | 84.15 | 526.70 |
| Days of Sales Outstanding | 56.40 | 45.73 | 70.48 | 89.79 | 417.99 |
| Days of Inventory Outstanding | 144.17 | 130.09 | 126.65 | 90.18 | 152.77 |
| Days of Payables Outstanding | 48.67 | 56.13 | 66.98 | 95.83 | 44.06 |
| Operating Cycle | 200.57 | 175.82 | 197.13 | 179.98 | 570.76 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.04 | 0.59 | -1.45 | -0.29 | -0.56 |
| Free Cash Flow Per Share | -0.24 | 0.33 | -1.71 | -0.31 | -0.57 |
| Dividend Paid and CapEx Coverage Ratio | 0.04 | 0.34 | -1.27 | -0.11 | -0.34 |
| Capital Expenditure Coverage Ratio | 0.13 | 2.30 | -5.69 | -25.16 | -53.86 |
| Operating Cash Flow Coverage Ratio | 0.01 | 0.06 | -0.17 | -0.05 | -0.07 |
| Operating Cash Flow to Sales Ratio | 0.02 | 0.26 | -0.69 | -0.25 | -0.72 |
| Free Cash Flow Yield | -0.60% | 0.83% | -4.26% | -0.79% | -1.32% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 3.21 | -25.65 | -26.80 | -43.73 | 15.19 |
| Price-to-Sales (P/S) Ratio | 19.76 | 17.44 | 19.14 | 32.68 | 55.17 |
| Price-to-Book (P/B) Ratio | 1.13 | 1.56 | 1.35 | 1.30 | 1.46 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -165.46 | 120.12 | -23.50 | -127.08 | -75.63 |
| Price-to-Operating Cash Flow Ratio | 1102.82 | 67.87 | -27.69 | -132.13 | -77.03 |
| Price-to-Earnings Growth (PEG) Ratio | -0.00 | -7.69 | -0.39 | 0.33 | -0.28 |
| Enterprise Value Multiple | 2.88 | -143.30 | -39.95 | 119.43 | 11.93 |
| Enterprise Value | 34.42B | 33.30B | 30.60B | 27.77B | 32.59B |
| EV to EBITDA | 2.88 | -143.30 | -39.95 | 119.43 | 11.93 |
| EV to Sales | 22.70 | 20.59 | 21.95 | 36.17 | 65.17 |
| EV to Free Cash Flow | -190.13 | 141.79 | -26.95 | -140.64 | -89.35 |
| EV to Operating Cash Flow | 1267.25 | 80.11 | -31.76 | -146.23 | -91.01 |
| Tangible Book Value Per Share | 34.06 | 24.34 | 29.22 | 29.86 | 33.21 |
| Shareholders’ Equity Per Share | 35.03 | 25.44 | 29.77 | 29.87 | 29.82 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.19 | 0.06 | 0.06 | 0.02 | 0.17 |
| Revenue Per Share | 2.01 | 2.28 | 2.10 | 1.19 | 0.79 |
| Net Income Per Share | 12.33 | -1.55 | -1.50 | -0.89 | 2.86 |
| Tax Burden | 0.81 | 0.94 | 0.89 | 0.98 | 0.70 |
| Interest Burden | 0.98 | 2.97 | 1.22 | -2.95 | 0.96 |
| Research & Development to Revenue | 0.06 | 0.04 | 0.06 | 0.06 | 0.15 |
| SG&A to Revenue | 0.30 | 0.27 | 0.33 | 0.37 | 0.88 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Income Quality | 0.00 | -0.36 | 0.86 | 0.32 | -0.14 |
Currency in TWD
